{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:47:04Z","timestamp":1784209624078,"version":"3.55.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"5","funder":[{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["P30 CA 240139"],"award-info":[{"award-number":["P30 CA 240139"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["P30 CA 008748"],"award-info":[{"award-number":["P30 CA 008748"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ionizing radiotherapy (RT) is a widely used treatment strategy for malignancies. In solid tumors, RT-induced double-strand breaks lead to the accumulation of insertion-deletions (indels; ID), and their repair by nonhomologous end joining has been linked to the ID8 mutational signature in surviving cells. However, the extent of RT-induced mutagenesis in hematologic malignancies and its impact on their mutational profiles and interplay with commonly used chemotherapies has not yet been explored. In this study, we interrogated 580 whole-genome sequence (WGS) samples from patients with large B-cell lymphoma, multiple myeloma, and myeloid neoplasms and identified ID8 only in relapsed disease. Yet ID8 was detected after exposure to both RT and mutagenic chemotherapy (i.e., platinum and melphalan). Using WGS of single-cell colonies derived from treated lymphoma cells, we revealed a dose\u2013response relationship between RT and platinum and ID8. Finally, using ID8 as a genomic barcode, we demonstrate that a single RT-surviving cell may seed distant relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>RT and the ID8 indel signature are related, but their genomic impact on hematologic malignancies is unclear. Leveraging WGS, we linked ID8 to both RT and mutagenic chemotherapy and validated that platinum can induce ID8. We used ID8 as a genomic barcode to reveal that RT-resistant cells may seed systemic relapse.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-24-0328","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:32:06Z","timestamp":1747913526000},"page":"450-463","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8638-9365","authenticated-orcid":false,"given":"Benjamin","family":"Diamond","sequence":"first","affiliation":[{"name":"1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7623-7018","authenticated-orcid":false,"given":"Dhanvantri","family":"Chahar","sequence":"additional","affiliation":[{"name":"2Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-1257","authenticated-orcid":false,"given":"Michael D.","family":"Jain","sequence":"additional","affiliation":[{"name":"3Lymphoma Service, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4325-3933","authenticated-orcid":false,"given":"Alexandra M.","family":"Poos","sequence":"additional","affiliation":[{"name":"4Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."},{"name":"5Clinical Cooperation Unit Molecular Hematology\/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-6847","authenticated-orcid":false,"given":"Michael A.","family":"Durante","sequence":"additional","affiliation":[{"name":"1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2746-0053","authenticated-orcid":false,"given":"Bachisio","family":"Ziccheddu","sequence":"additional","affiliation":[{"name":"1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4529-7405","authenticated-orcid":false,"given":"Marcella","family":"Kaddoura","sequence":"additional","affiliation":[{"name":"1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1852-3495","authenticated-orcid":false,"given":"Marios","family":"Papadimitriou","sequence":"additional","affiliation":[{"name":"1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-4854","authenticated-orcid":false,"given":"Kylee H.","family":"Maclachlan","sequence":"additional","affiliation":[{"name":"6Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-9253","authenticated-orcid":false,"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[{"name":"7Department of Hemato-Oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-2393","authenticated-orcid":false,"given":"Faith E.","family":"Davies","sequence":"additional","affiliation":[{"name":"8Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-3320","authenticated-orcid":false,"given":"Nicholas B.","family":"Figura","sequence":"additional","affiliation":[{"name":"9Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4271-6360","authenticated-orcid":false,"given":"Gareth J.","family":"Morgan","sequence":"additional","affiliation":[{"name":"8Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-1252","authenticated-orcid":false,"given":"Elias K.","family":"Mai","sequence":"additional","affiliation":[{"name":"4Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."},{"name":"10German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-6614","authenticated-orcid":false,"given":"Katja","family":"Weisel","sequence":"additional","affiliation":[{"name":"11Department of Oncology, Hematology and Blood and Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-6288","authenticated-orcid":false,"given":"Roland","family":"Fenk","sequence":"additional","affiliation":[{"name":"12Department of Hematology, Oncology and Clinical Immunology, University-Hospital Duesseldorf, Duesseldorf, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-6922","authenticated-orcid":false,"given":"Marc S.","family":"Raab","sequence":"additional","affiliation":[{"name":"4Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."},{"name":"5Clinical Cooperation Unit Molecular Hematology\/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany."},{"name":"10German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-8731","authenticated-orcid":false,"given":"Saad","family":"Usmani","sequence":"additional","affiliation":[{"name":"6Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-4839","authenticated-orcid":false,"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[{"name":"1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9063-6691","authenticated-orcid":false,"given":"Frederick L.","family":"Locke","sequence":"additional","affiliation":[{"name":"3Lymphoma Service, Moffitt Cancer Center, Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0961-0035","authenticated-orcid":false,"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[{"name":"4Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."},{"name":"10German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1842-228X","authenticated-orcid":false,"given":"Jonathan Harry","family":"Schatz","sequence":"additional","affiliation":[{"name":"2Lymphoma Service, Sylvester Comprehensive Cancer Center, Miami, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5464-3234","authenticated-orcid":false,"given":"Niels","family":"Weinhold","sequence":"additional","affiliation":[{"name":"4Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."},{"name":"5Clinical Cooperation Unit Molecular Hematology\/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, German Cancer Research Center (DKFZ), Heidelberg, Germany."},{"name":"10German-Speaking Myeloma Multicenter Group (GMMG), Heidelberg Myeloma Center, Department of Internal Medicine V, Heidelberg University Hospital, Medical Faculty, Heidelberg University, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-1620","authenticated-orcid":false,"given":"Francesco","family":"Maura","sequence":"additional","affiliation":[{"name":"1Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida."},{"name":"6Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2025100710320622000_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fonc.2015.00040","article-title":"Current role of radiation therapy for multiple myeloma","volume":"5","author":"Talamo","year":"2015","journal-title":"Front Oncol"},{"key":"2025100710320622000_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","article-title":"Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA","volume":"17","author":"Thumallapally","year":"2017","journal-title":"BMC Cancer"},{"key":"2025100710320622000_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2025100710320622000_bib4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41588-021-00874-3","article-title":"Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer","volume":"53","author":"Kocakavuk","year":"2021","journal-title":"Nat Genet"},{"key":"2025100710320622000_bib5","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41588-019-0525-5","article-title":"The mutational footprints of cancer therapies","volume":"51","author":"Pich","year":"2019","journal-title":"Nat Genet"},{"key":"2025100710320622000_bib6","first-page":"2359","article-title":"Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures","volume":"141","author":"Diamond","year":"2023","journal-title":"Blood"},{"key":"2025100710320622000_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"2025100710320622000_bib8","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1038\/ncomms12605","article-title":"Mutational signatures of ionizing radiation in second malignancies","volume":"7","author":"Behjati","year":"2016","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","article-title":"A compendium of mutational signatures of environmental agents","volume":"177","author":"Kucab","year":"2019","journal-title":"Cell"},{"key":"2025100710320622000_bib10","doi-asserted-by":"crossref","first-page":"100499","DOI":"10.1016\/j.xgen.2024.100499","article-title":"Quantitative and qualitative mutational impact of ionizing radiation on normal cells","volume":"4","author":"Youk","year":"2024","journal-title":"Cell Genomics"},{"key":"2025100710320622000_bib11","doi-asserted-by":"crossref","first-page":"abl9283","DOI":"10.1126\/science.abl9283","article-title":"Substitution mutational signatures in whole-genome\u2013sequenced cancers in the UK population","volume":"376","author":"Degasperi","year":"2022","journal-title":"Science"},{"key":"2025100710320622000_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"key":"2025100710320622000_bib13","first-page":"1860","article-title":"Elevated mutational age in blood of children treated for cancer contributes to therapy-related myeloid neoplasms","volume":"12","author":"Bertrums","year":"2022","journal-title":"Cancer Discov"},{"key":"2025100710320622000_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.2021015008","article-title":"Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma","volume":"140","author":"Jain","year":"2022","journal-title":"Blood"},{"key":"2025100710320622000_bib15","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/s41467-020-15740-9","article-title":"Timing the initiation of multiple myeloma","volume":"11","author":"Rustad","year":"2020","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/2159-8290.CD-23-1186","article-title":"Origins of second malignancies in children and mutational footprint of chemotherapy in normal tissues","volume":"14","author":"S\u00e1nchez-Guix\u00e9","year":"2024","journal-title":"Cancer Discov"},{"key":"2025100710320622000_bib17","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/s41467-024-50384-z","article-title":"Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms","volume":"15","author":"Bertrums","year":"2024","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib18","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.stem.2021.07.012","article-title":"Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients","volume":"28","author":"de Kanter","year":"2021","journal-title":"Cell Stem Cell"},{"key":"2025100710320622000_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12885-019-5677-2","article-title":"Portrait of a cancer: mutational signature analyses for cancer diagnostics","volume":"19","author":"Van Hoeck","year":"2019","journal-title":"BMC cancer"},{"key":"2025100710320622000_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41586-024-07955-3","article-title":"The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution","volume":"635","author":"Nguyen","year":"2024","journal-title":"Nature"},{"key":"2025100710320622000_bib21","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1038\/ncomms7684","article-title":"The genome-wide effects of ionizing radiation on mutation induction in the mammalian germline","volume":"6","author":"Adewoye","year":"2015","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib22","doi-asserted-by":"crossref","first-page":"e0258269","DOI":"10.1371\/journal.pone.0258269","article-title":"C. elegans genome-wide analysis reveals DNA repair pathways that act cooperatively to preserve genome integrity upon ionizing radiation","volume":"16","author":"Meier","year":"2021","journal-title":"PLoS One"},{"key":"2025100710320622000_bib23","doi-asserted-by":"crossref","first-page":"e2114024119","DOI":"10.1073\/pnas.2114024119","article-title":"Recurrent mutations in topoisomerase II\u03b1 cause a previously undescribed mutator phenotype in human cancers","volume":"119","author":"Boot","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025100710320622000_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"key":"2025100710320622000_bib25","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/S2352-3026(23)00366-6","article-title":"Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial","volume":"11","author":"Mai","year":"2024","journal-title":"Lancet Haematol"},{"key":"2025100710320622000_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.2024024299","article-title":"The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma","volume":"144","author":"Cirrincione","year":"2024","journal-title":"Blood"},{"key":"2025100710320622000_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature13968","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","author":"Wong","year":"2015","journal-title":"Nature"},{"key":"2025100710320622000_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jms.1009","article-title":"Quantitative determination of melphalan DNA adducts using HPLC-inductively coupled mass spectrometry","volume":"41","author":"Edler","year":"2006","journal-title":"J Mass Spectrom"},{"key":"2025100710320622000_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-2952(03)00260-0","article-title":"DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells","volume":"66","author":"Faivre","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"2025100710320622000_bib30","doi-asserted-by":"crossref","first-page":"e55493","DOI":"10.1371\/journal.pone.0055493","article-title":"An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells","volume":"8","author":"Sousa","year":"2013","journal-title":"PLoS One"},{"key":"2025100710320622000_bib31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/09553009014551251","article-title":"The yield of DNA double-strand breaks produced intracellularly by ionizing radiation: a review","volume":"57","author":"Ward","year":"1990","journal-title":"Int J Radiat Biol"},{"key":"2025100710320622000_bib32","doi-asserted-by":"crossref","first-page":"24263","DOI":"10.1074\/jbc.M112.344911","article-title":"Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways","volume":"287","author":"Sears","year":"2012","journal-title":"J Biol Chem"},{"key":"2025100710320622000_bib33","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1038\/s41467-019-11037-8","article-title":"A practical guide for mutational signature analysis in hematological malignancies","volume":"10","author":"Maura","year":"2019","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s42003-021-01938-0","article-title":"mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies","volume":"4","author":"Rustad","year":"2021","journal-title":"Commun Biol"},{"key":"2025100710320622000_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-022-04403-y","article-title":"Signatures of TOP1 transcription-associated mutagenesis in cancer and germline","volume":"602","author":"Reijns","year":"2022","journal-title":"Nature"},{"key":"2025100710320622000_bib36","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1200\/JCO.23.01277","article-title":"Genomic classification and individualized prognosis in multiple myeloma","volume":"42","author":"Maura","year":"2024","journal-title":"J Clin Oncol"},{"key":"2025100710320622000_bib37","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41467-020-16323-4","article-title":"The mutational impact of culturing human pluripotent and adult stem cells","volume":"11","author":"Kuijk","year":"2020","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-018-0497-0","article-title":"Population dynamics of normal human blood inferred from somatic mutations","volume":"561","author":"Lee-Six","year":"2018","journal-title":"Nature"},{"key":"2025100710320622000_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","article-title":"Clonal dynamics of haematopoiesis across the human lifespan","volume":"606","author":"Mitchell","year":"2022","journal-title":"Nature"},{"key":"2025100710320622000_bib40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2024.02.009","article-title":"Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer","volume":"42","author":"Rosendahl Huber","year":"2024","journal-title":"Cancer Cell"},{"key":"2025100710320622000_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"},{"key":"2025100710320622000_bib42","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1038\/s41467-020-17459-z","article-title":"Accelerated single cell seeding in relapsed multiple myeloma","volume":"11","author":"Landau","year":"2020","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib43","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1038\/ncomms9683","article-title":"A mutational signature in gastric cancer suggests therapeutic strategies","volume":"6","author":"Alexandrov","year":"2015","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib44","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1038\/s41467-022-32145-y","article-title":"The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states","volume":"13","author":"Rasche","year":"2022","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib45","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1038\/s41467-021-24858-3","article-title":"The evolution of hematopoietic cells under cancer therapy","volume":"12","author":"Pich","year":"2021","journal-title":"Nat Commun"},{"key":"2025100710320622000_bib46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jbiotec.2017.08.006","article-title":"OTP: an automatized system for managing and processing NGS data","volume":"261","author":"Reisinger","year":"2017","journal-title":"J Biotechnol"},{"key":"2025100710320622000_bib47","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ng.3036","article-title":"Integrating mapping-assembly-and haplotype-based approaches for calling variants in clinical sequencing applications","volume":"46","author":"Rimmer","year":"2014","journal-title":"Nat Genet"},{"key":"2025100710320622000_bib48","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"2025100710320622000_bib49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/2643-3230.BCD-20-0132","article-title":"Revealing the impact of structural variants in multiple myeloma","volume":"1","author":"Rustad","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"2025100710320622000_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s43018-020-0027-5","article-title":"A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies","volume":"1","author":"Degasperi","year":"2020","journal-title":"Nat Cancer"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-24-0328\/3608840\/bcd-24-0328.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-24-0328\/3639943\/bcd-24-0328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/5\/450\/3646197\/bcd-24-0328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/6\/5\/450\/3646197\/bcd-24-0328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:32:27Z","timestamp":1759847547000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/6\/5\/450\/764332\/Mutagenic-Impact-and-Evolutionary-Influence-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,22]]},"published-print":{"date-parts":[[2025,9,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-24-0328","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.8014461","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.30040899","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30296458","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30296455","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30040902","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}